Quantcast

Latest Clinical trial Stories

2014-06-19 08:28:24

REDWOOD CITY, Calif., June 19, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 25th. Presentation details are as follows: JMP Securities Healthcare ConferenceDate: Wednesday, June 25thLocation: The Westin New York Grand Central,...

2014-06-18 16:26:53

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it is currently enrolling patients in two nationwide clinical trials to evaluate its monoclonal antibody for canine T-cell lymphoma, AT-005, which is conditionally licensed by the USDA to aid in the treatment of...

2014-06-18 08:24:53

MORRISTOWN, N.J., June 18, 2014 /PRNewswire/ -- Atlantic Health System has launched a new website that provides information about open and enrolling clinical trials and research studies across Atlantic Health System medical centers. The tablet and smartphone-friendly website, atlantichealth.org/research, features a search tool that allows visitors to easily find trials based on disease area, keywords, and the name of physicians conducting trials. Atlantic Health System, which...

2014-06-17 23:09:08

Wireless Solution Delivers Cost Savings and Real-time Access to Key Patient Data Philadelphia, PA (PRWEB) June 17, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its AM3® GSM devices in respiratory clinical trials. The AM3 GSM device provides a robust and reliable wireless option for clinical trial patients to...

2014-06-17 12:29:42

Provider of patient-driven eData Systems will run data collection system on Dell Venue 11 Pro tablets with Windows 8.1. REDMOND, Wash., June 17, 2014 /PRNewswire/ -- PHT Corporation, the leading provider of technologies used to collect patient-driven electronic data for clinical research, has selected Dell Venue 11 Pro tablets featuring Windows 8.1 to run its SitePad(®) System. The SitePad System replaces traditional paper data collection methods in clinical research with electronic...

2014-06-17 08:30:28

SAN DIEGO and BOSTON, June 17, 2014 /PRNewswire/ -- DIA 2014 50th Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, and CROee, the first consulting Japanese CRO specializing in patient recruitment, today announced the creation of a jointly-owned US-based company, BBK + CROee. Collaborators since 2010, the new partners formed the entity to provide the cultural and marketing expertise necessary to engage the Japanese pharmaceutical industry and, in turn, to support...

2014-06-17 08:30:10

MOMENCE, Ill., June 17, 2014 /PRNewswire/ -- FutureCeuticals, Inc. today announced publication of the results of another successful human clinical study on FruiteX-B® calcium fructoborate, a patented plant mineral complex. The double-blind, placebo-controlled study examined the effects of FruiteX-B® supplementation during fourteen days on subjects with self-reported knee discomfort. The study population was equally divided between generally healthy men and women ranging in ages...

2014-06-17 08:28:28

Previously released interim results from the trial showed positive safety and efficacy; 300 patients with moderate to severe disease were enrolled in the study PETACH TIKVA, Israel, June 17, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has finalized enrollment in its Phase II/III trial of CF101 for the treatment...

2014-06-17 04:21:02

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, June 17, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Incyte Corporation (NASDAQ: INCY), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), Arrowhead Research Corp. (NASDAQ: ARWR), Novavax, Inc. (NASDAQ: NVAX) and Chelsea Therapeutics International Ltd. (NASDAQ: CHTP). Private wealth members receive these notes ahead of publication. To reserve complementary...

2014-06-16 23:06:45

DIARYpro® Available on Patients’ Smartphones – Delivering Reliability while Reducing Trial Costs Philadelphia (PRWEB) June 16, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its comprehensive suite of electronic Clinical Outcome Assessment (eCOA) data collection solutions for use in clinical trials. With this expansion, clinical trial sponsors can improve trial efficiencies while...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related